How A Rare Disease Biotech Replaced Manual Processes With RTSM Software

Transitioning from manual tracking to automated systems is often a tipping point for clinical-stage biotechs. This case study explores how a genetic medicines company navigating a Phase I/II respiratory trial moved away from the risks of "management by spreadsheet." In rare disease research, where every patient is vital and inclusion criteria are exceptionally narrow, the margin for error in drug supply is non-existent. Explore the shift from resource-heavy manual processes to a sophisticated RTSM solution, highlighting a common industry friction point: the struggle of smaller sponsors to find high-touch partnership and flexibility from legacy vendors. By prioritizing specialized expertise and a consultative design process, this study demonstrates how automated supply logistics and intuitive interfaces can safeguard a trial against participant loss.